Longevity Health Holdings XAGE

Longevity Health Holdings, Inc. is focused on longevity and healthy aging through regenerative bio-aesthetic products. The company develops and commercializes cosmetic skincare and haircare solutions designed to support skin and hair health. Its core activities center on two product lines: Elevai Exosomes TM and Carmell Secretome TM , both aimed at professional care providers and retail consumers seeking advanced aesthetic outcomes.

Longevity Health Holdings, Inc. generates revenue primarily through the sale of its cosmetic skincare and haircare products. These include Elevai Empower TM , Elevai Enfinity TM , Elevai Renew TM Scalp Serum, Elevai HOCL Allantoin Active Cleanser TM , and Elevai Hyper-Hydrating Booster TM under the Elevai Exosomes TM line. The Carmell Secretome TM line includes the Face and Neck Collection (Retail) with Regenerative Elixir, Brightening Glow, and Hydrating Dew, and the ProSynergy Collection (Doctors/Medspas) featuring ReInforce, ReTone, ReTexture, ReTone HP, and Rapid Recovery Crème. Revenue is derived from business-to-business sales to physicians and medical spas, direct-to-consumer online sales, and distributor partnerships in domestic and international markets.

The company operates through the following segments:

• Cosmetic Skincare and Haircare: This segment encompasses the development, manufacturing, and sale of topical aesthetic products under the Elevai Exosomes TM and Carmell Secretome TM brands. The Elevai Exosomes TM line includes skincare products such as Elevai Empower TM and Elevai Enfinity TM , as well as haircare offerings like Elevai Renew TM Scalp Serum and the recently launched Elevai HOCL Allantoin Active Cleanser TM and Elevai Hyper-Hydrating Booster TM . The Carmell Secretome TM line features the Face and Neck Collection (Retail) with Regenerative Elixir, Brightening Glow, and Hydrating Dew, and the ProSynergy Collection (Doctors/Medspas) including ReInforce, ReTone, ReTexture, ReTone HP, and Rapid Recovery Crème. All products are formulated with biologically active ingredients and manufactured in compliance with cGMP and GLP standards in the United States.
• Bone and Tissue Healing Products: This segment includes the Bone Healing Accelerant (BHA) and Tissue Healing Accelerant (THA) product candidates based on technology licensed from Carnegie Mellon University. BHA is designed as a putty-form biologic for applications such as trauma fixation surgeries, spinal fusion, and dental bone grafts, incorporating b-Tri-Calcium Phosphate (b-TCP). THA is a paste-formulation intended for chronic wound care and aesthetic uses, similar to BHA but without the b-TCP component. Both candidates have undergone preclinical testing and BHA has received FDA fast-track designation for severe open tibia fractures, though further development has been paused to prioritize commercialization of the cosmetic product lines.

Longevity Health Holdings, Inc. operates in the competitive global skincare and haircare market, which grew 7% annually from 2022 to 2024 and is projected to grow at 5% annually through 2030 according to a June 2025 McKinsey & Company study. The company positions itself within the physician-dispensed and medical aesthetics channels, competing against large multinational brands such as L’Oréal, Estée Lauder, Coty, Revlon, Shiseido, Johnson & Johnson, and Procter & Gamble, while also facing competition from emerging independent brands offering specialized formulations. Its competitive advantage lies in its proprietary exosome and secretome-based technologies, which are designed to enhance ingredient delivery and support skin regeneration without relying on common harmful excipients.

The company serves physicians’ offices, medical spas, dermatologists, plastic surgeons, and other medical aesthetics professionals through its business-to-business sales channel. It also sells directly to consumers via its online retail platforms and partners with distributors in both domestic and international markets. Specific customer types include licensed medical professionals seeking adjunctive skincare for pre- and post-procedural care, as well as individual consumers purchasing products for daily use and maintenance of skin and hair health.